- ￥2000 - 5000
- 齐源
- 354207
- 国产/进口
- 2025年07月12日
- FC
- 小鼠
- 人
6 年钻石会员
企业认证
相关产品推荐更多 >
万千商家帮你免费找货
0 人在求购买到急需产品
- 详细信息
- 文献和实验
- 技术资料
- 供应商：
齐源
- 库存：
999
- 靶点：
CD303 (BDCA-2)
- 级别：
CD303 (BDCA-2) Antibody
- 目录编号：
CD303 (BDCA-2) Antibody
- 克隆性：
单克隆
- 抗原来源：
小鼠
- 保质期：
CD303 (BDCA-2) Antibody
- 抗体英文名：
anti-human CD303 (BDCA-2) Antibody-FITC
- 抗体名：
CD303 (BDCA-2) Antibody
- 标记物：
FITC
- 宿主：
小鼠
- 适应物种：
人
- 免疫原：
CD303 (BDCA-2) Antibody
- 亚型：
CD303 (BDCA-2) Antibody
- 形态：
CD303 (BDCA-2) Antibody
- 应用范围：
FC
- 保存条件：
2-8℃
- 浓度：
CD303 (BDCA-2) Antibody
- 规格：
25 tests/100 tests
| 规格： | 25 tests | 产品价格： | ￥2000.0 |
|---|---|---|---|
| 规格： | 100 tests | 产品价格： | ￥5000.0 |
anti-human CD303 (BDCA-2) Antibody-FITC详细如下：
Description ：CD303, also known as BDCA-2 and CLEC4C, is a 38 kD type II transmembrane glycoprotein. Itis a member of the C-type lectin superfamily. CD303 is expressed by plasmacytoid dendriticcells (pDCs) and is involved in cell adhesion, signaling, and antigen capture and processing.Crosslinking of CD303 inhibits the production of IFN-α/β and TLR-9 induced pDCs maturation.
Verified Reactivity ：Human
Antibody Type ：Monoclonal
Host Species ：Mouse
Formulation ：Phosphate-buffered solution, pH 7.2, containing 0.09% sodium azide and BSA (origin USA)
Preparation ：The antibody was purified by affinity chromatography, and conjugated with FITC under optimalconditions.
Concentration ：Lot-specific (to obtain lot-specific concentration and expiration, please enter the lot number in ourCertificate of Analysis online tool.)
Storage & Handling ：The antibody solution should be stored undiluted between 2°C and 8°C, and protected fromprolonged exposure to light. Do not freeze.
Application ：FC - Quality tested
Recommended Usage ：Each lot of this antibody is quality control tested by immunofluorescent staining with flow cytometricanalysis. For flow cytometric staining, the suggested use of this reagent is 5 µl per million cells in100 µl staining volume or 5 µl per 100 µl of whole blood.
Excitation Laser ：Blue Laser (488 nm)
Description ：CD303, also known as BDCA-2 and CLEC4C, is a 38 kD type II transmembrane glycoprotein. Itis a member of the C-type lectin superfamily. CD303 is expressed by plasmacytoid dendriticcells (pDCs) and is involved in cell adhesion, signaling, and antigen capture and processing.Crosslinking of CD303 inhibits the production of IFN-α/β and TLR-9 induced pDCs maturation.
Verified Reactivity ：Human
Antibody Type ：Monoclonal
Host Species ：Mouse
Formulation ：Phosphate-buffered solution, pH 7.2, containing 0.09% sodium azide and BSA (origin USA)
Preparation ：The antibody was purified by affinity chromatography, and conjugated with FITC under optimalconditions.
Concentration ：Lot-specific (to obtain lot-specific concentration and expiration, please enter the lot number in ourCertificate of Analysis online tool.)
Storage & Handling ：The antibody solution should be stored undiluted between 2°C and 8°C, and protected fromprolonged exposure to light. Do not freeze.
Application ：FC - Quality tested
Recommended Usage ：Each lot of this antibody is quality control tested by immunofluorescent staining with flow cytometricanalysis. For flow cytometric staining, the suggested use of this reagent is 5 µl per million cells in100 µl staining volume or 5 µl per 100 µl of whole blood.
Excitation Laser ：Blue Laser (488 nm)
风险提示：丁香通仅作为第三方平台，为商家信息发布提供平台空间。用户咨询产品时请注意保护个人信息及财产安全，合理判断，谨慎选购商品，商家和用户对交易行为负责。对于医疗器械类产品，请先查证核实企业经营资质和医疗器械产品注册证情况。
文献和实验该产品被引用文献
Application References(PubMed link indicatesBioLegend citation)：
1. Freeman A, et al. 2014. PLoS One. 9:110928. PubMed
2. Johnson P, et al. 2015. Clin Cnacer Res. 21:1321. PubMed
Product Citations：
1. Woo MS, et al. 2021. iScience. 24(7):102752. PubMed
2. Cignarella F et al. 2018. Cell metabolism. 27(6):1222-1235 . PubMed
3. Alcántara‐Hernández M et al. 2017. Immunity. 47(6):1037-1050 . PubMed
4. Zhou R, et al. 2020. Immunity. S1074-7613(20)30333-2.. PubMed
5. Laing AG, et al. 2020. Nat Med. 26:1623. PubMed
6. Hansen IS, et al. 2018. Nat Commun. 9:863. PubMed
7. Yang R, et al. 2020. Cell. 183(7):1826-1847.e31. PubMed
8. Leylek R, et al. 2019. Cell Rep. 29:3736. PubMed
9. Georgakis S, et al. 2021. JCI Insight. 6:. PubMed
10. Golebski K, et al. 2021. Immunity. 54(2):291-307.e7. PubMed
11. Lee J, et al. 2015. J Exp Med. 212:385. PubMed
12. Singh A, et al. 2020. Cell Rep. 32:108153. PubMed
1. Freeman A, et al. 2014. PLoS One. 9:110928. PubMed
2. Johnson P, et al. 2015. Clin Cnacer Res. 21:1321. PubMed
Product Citations：
1. Woo MS, et al. 2021. iScience. 24(7):102752. PubMed
2. Cignarella F et al. 2018. Cell metabolism. 27(6):1222-1235 . PubMed
3. Alcántara‐Hernández M et al. 2017. Immunity. 47(6):1037-1050 . PubMed
4. Zhou R, et al. 2020. Immunity. S1074-7613(20)30333-2.. PubMed
5. Laing AG, et al. 2020. Nat Med. 26:1623. PubMed
6. Hansen IS, et al. 2018. Nat Commun. 9:863. PubMed
7. Yang R, et al. 2020. Cell. 183(7):1826-1847.e31. PubMed
8. Leylek R, et al. 2019. Cell Rep. 29:3736. PubMed
9. Georgakis S, et al. 2021. JCI Insight. 6:. PubMed
10. Golebski K, et al. 2021. Immunity. 54(2):291-307.e7. PubMed
11. Lee J, et al. 2015. J Exp Med. 212:385. PubMed
12. Singh A, et al. 2020. Cell Rep. 32:108153. PubMed
文献支持
抗人 CD303 (BDCA-2) 荧光标记FITC 抗体
￥2000 - 5000
